Pharmaceutical manufacturers often use revenue management systems (ex. Model N, Vistex/SAP) to manage revenue processes, like chargebacks, that determine which customers should pay which prices for which products.

Today, even with revenue management systems well established, manufacturers still require substantial manual processing to evaluate customer contract eligibility and resolve chargeback errors with wholesalers. The result:  unnecessary manual effort, revenue leakage and customer add/re-bills that nobody wants.

The purpose of this whitepaper is:

To explain symbiotic relationship between the MediLedger network and revenue systems

To walkthrough the value generated from combining your revenue management system with MediLedger

To illustrate a vision for the future of the pharmaceutical industry